Background Rituximab continues to be found in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) since 2003. cyclophosphamide had been likened using Kaplan-Meier curves. Rituximab-treated individuals had been characterized in comparison to AAV individuals treated with cyclophosphamide however not subjected to rituximab (= 351) using Fisher’s precise or rank testing. Results Rituximab led to 86% attaining remission… Continue reading Background Rituximab continues to be found in antineutrophil cytoplasmic antibody (ANCA)-associated